• Home
  • Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Author List
Shankar-Hari M, Calfee CS
Publication
JAMA
Publication ID (Profile URL)
https://researcherprofiles.org/profile/95361400
Publication Year
2020
PubMed ID
32065830
Publication Title
Shankar-Hari M, Calfee CS. Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS? JAMA. 2020 02 25; 323(8):713-715.